SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing Homes

Central Hospital, Nancy, France1,293 enrolled

Overview

Presence of SaRS-Cov-2 antibodies following exposure to Coronavirus Disease 2019 (COVID-19) and/or vaccination is a major indicator of immunization. Few data exit about serology response in nursing homes (NHs), i.e. in the most vulnerable population for developing severe forms of the disease. Residents and health professionals in 9 nursing homes (NHs) with SaRS-Cov-2 antibodies detection after exposure (either COVID-19 or vaccine) All biological tests were performed in the frame of the standard care of residents and health professionals and all participants did not express opposition for using anonymously their data for the purpose of this academic analysis. In addition all Directors and Physicians of these NHs accepted to participate in this study

Study Type

OBSERVATIONAL

Enrollment

1,293

Conditions

COVID-19 Infection

Interventions

SARS-CoV-2 antibodiesDIAGNOSTIC_TEST

Analysis of the results of the serological response to COVID-19 and/or Vaccine

Eligibility

Medical Language ↔ Plain English

Inclusion Criteria: For Residents: * Living in one of the 9 Nursing Homes that participate in this study * Having a SARS-COV-2 post vaccination serology. * Having no objection for using the results of the serology for the purpose of this analysis For Health Professionals: * Working in one of the 9 Nursing Homes that participate in this study, * Having a SARS-COV-2 post vaccination serology. * Having no objection for using the results of the serology for the purpose of this analysis Exclusion Criteria: * None

Outcomes

Primary Outcomes

Levels of SARS-COV-2 antibodies

Study of the SARS-COV-2 antibodies according to the history of COVID-19 and vaccinal status in Nursing Home residents and in health professionals

Time frame: Through study completion average 6 months Retrospective analysis